Group One Trading’s Oric Pharmaceuticals ORIC Stock Holding History

Group One Trading’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-700	Closed	-$3.91K	–	8460
2025 Q1	$3.91K	Buy	+700	New	+$6.12K	﹤0.01%	6744
2024 Q4	–	Sell	-5,100	Closed	-$52.3K	–	7771
2024 Q3	$52.3K	Buy	5,100 +100	+2%	+$989	﹤0.01%	4632
2024 Q2	$35.4K	Hold	5,000	–	–	﹤0.01%	4784
2024 Q1	$68.8K	Buy	+5,000	New	+$59.4K	﹤0.01%	4443
2023 Q4	–	Sell	-6,600	Closed	-$39.9K	–	7968
2023 Q3	$39.9K	Buy	6,600 +6,200	+1,550%	+$50.8K	﹤0.01%	5309
2023 Q2	$3.1K	Buy	+400	New	+$2.27K	﹤0.01%	6931
2023 Q1	–	Sell	-11,800	Closed	-$69.5K	–	7735
2022 Q4	$69.5K	Buy	+11,800	New	+$39.8K	﹤0.01%	4755
2022 Q3	–	Sell	-200	Closed	-$1K	–	8041
2022 Q2	$1K	Hold	200	–	–	﹤0.01%	7597
2022 Q1	$1K	Buy	+200	New	+$1.8K	﹤0.01%	7855

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Group One Trading's ORIC Position: Q1 2026 in Review

Group One Trading opened a new position in Oric Pharmaceuticals (ORIC) in Q1 2026: 100 shares worth $1.27K. The stake represents ﹤0.01% of the portfolio and ranks #7168 among its holdings. This is a return to the name: Group One Trading previously reported a position in ORIC as recently as Q2 2025.

Group One Trading first reported a position in ORIC in Q2 2022 and has held it in 7 quarters since. The position peaked at $32.6K in Q2 2023. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

Group One Trading held 100 shares of Oric Pharmaceuticals worth $1.27K as of Q1 2026.
Oric Pharmaceuticals was a new Group One Trading position in Q1 2026.
Oric Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7168 holding.
Group One Trading first reported a position in Oric Pharmaceuticals in Q2 2022 and has held it in 7 quarters since.
Group One Trading's Oric Pharmaceuticals position peaked at $32.6K in Q2 2023.
182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.